Read This Before Trading the Following: TAGG, PROT, MIMV and ONCS
03 Octobre 2012 - 2:00PM
Marketwired
AnotherWinningTrade.com is the #1 leader for breaking news &
offers quality reports to investors looking for the most active
traded companies in the small cap market.
TagLikeMe Corp. (OTCQB: TAGG) owns and operates TagLikeMe.com,
an Internet services platform that combines the most commonly used
functions of search and social media. The company saw trade volume
surpassing 142 million shares yet the company closed down nearly
28%.
For a free report and detailed analysis on TAGG visit:
http://www.anotherwinningtrade.com/ael/?sym=TAGG
Proteonomix, Inc. (OTCQB: PROT) a biotechnology company focused
on developing therapeutics based upon the use of human cells and
their derivatives saw shares down 56% for the trading session. Our
exclusive report has the answers as to what caused this major
decline.
For a free report and detailed analysis on PROT visit:
http://www.anotherwinningtrade.com/ael/?sym=PROT
MIMVI, Inc. (OTCQB: MIMV) a search and recommendation technology
company has seen shares soaring following news the company
announced that it has finalized a partnership agreement with
Microsoft Corp. See our exclusive report to find out what could
happened next to the share price of MIMV.
For a free report and detailed analysis on MIMV visit:
http://www.anotherwinningtrade.com/ael/?sym=MIMV
OncoSec Medical Inc. (OTCQB: ONCS) a biopharmaceutical company
developing its advanced-stage ImmunoPulse, NeoPulse therapies to
treat solid tumor cancers has seen share prices starting to advance
higher. Find out what catalysts are behind this recent run up by
reading our exclusive ONCS report.
For a free report and detailed analysis on ONCS visit:
http://www.anotherwinningtrade.com/ael/?sym=ONCS
Information, opinions and analysis contained herein are based on
sources believed to be reliable, but no representation, expressed
or implied, is made as to its accuracy, completeness or
correctness. The opinions contained herein reflect our current
judgment and are subject to change without notice. We accept no
liability for any losses arising from an investor's reliance on or
use of this report. This report is for information purposes only,
and is neither a solicitation to buy nor an offer to sell
securities. A third party has hired and paid IO News Wire twelve
hundred and ninety five dollars for the publication and circulation
of this news release. Certain information included herein is
forward-looking within the meaning of the Private Securities
Litigation Reform Act of 1995, including, but not limited to,
statements concerning manufacturing, marketing, growth, and
expansion. Such forward-looking information involves important
risks and uncertainties that could affect actual results and cause
them to differ materially from expectations expressed herein. We
have no ownership of equity, no representation; do no trading of
any kind and send no faxes or emails.
IO Circuit Email Contact
Proteonomix (CE) (USOTC:PROT)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Proteonomix (CE) (USOTC:PROT)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025